KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Other Non-Current Assets (2016 - 2025)

Chemed (CHE) has 17 years of Other Non-Current Assets data on record, last reported at $8.1 million in Q3 2025.

  • For Q3 2025, Other Non-Current Assets changed N/A year-over-year to $8.1 million; the TTM value through Sep 2025 reached $8.1 million, changed N/A, while the annual FY2024 figure was $55.8 million, 0.25% changed from the prior year.
  • Other Non-Current Assets reached $8.1 million in Q3 2025 per CHE's latest filing, down from $55.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $56.7 million in Q2 2023 and bottomed at $2.2 million in Q1 2024.
  • Average Other Non-Current Assets over 5 years is $21.1 million, with a median of $8.6 million recorded in 2021.
  • The widest YoY moves for Other Non-Current Assets: up 1429.65% in 2023, down 55.73% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $8.1 million in 2021, then plummeted by 55.32% to $3.6 million in 2022, then skyrocketed by 1429.65% to $55.6 million in 2023, then increased by 0.25% to $55.8 million in 2024, then plummeted by 85.41% to $8.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $8.1 million in Q3 2025, $55.8 million in Q4 2024, and $2.2 million in Q1 2024.